Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

SLNSLN
Showing 8 of 14 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in Silence Therapeutics PLC Sponsored ADR

CITADEL ADVISORS LLC holds 1.3M shares of SLN (Silence Therapeutics PLC Sponsored ADR), worth $14.6M as of 2026-Q2. The position was increased (+7.7% shares). SLN represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$14.6M

Current Shares

1.3M

Total Value Change

+$6.7M

Total Shares Change

+892,928

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.3M
+7.7%
$14.6M0.0%$10.98
30
2026-Q1
Increased
1.2M
+405.9%
$6.5M0.0%$5.66
44
2025-Q4
Increased
244,061
+1034.9%
$1.5M0.0%$6.15
41
2025-Q3
New
21,505
-
$111,6110.0%$5.67
34
2025-Q2
Exited
0
-100.0%
$00.0%$5.79
0
2025-Q1
Decreased
62,441
-77.9%
$176,0840.0%$3.44
0
2024-Q4
Decreased
282,737
-35.3%
$1.9M0.0%$6.91
0
2024-Q3
Increased
436,697
+274.0%
$7.9M0.0%$18.25
44

Other major holders of SLN: MILLENNIUM MANAGEMENT LLC, Janus Henderson Group Ltd., Polar Capital Holdings Plc

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used